Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 676

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Open access
Lu, Xiaoyan, Wang, Lijuan, Sakthivel, Senthilkumar K., Whitaker, Brett, Murray, Janna, Kamili, Shifaq, Lynch, Brian, Malapati, Lakshmi, Burke, Stephen A., Harcourt, Jennifer, Tamin, Azaibi, Thornburg, Natalie J., Villanueva, Julie M., Lindstrom, Stephen·2020·Emerging Infectious Diseases

Abstract

O n December 31, 2019, an outbreak of an unex- plained acute respiratory disease, later designated coronavirus disease (COVID-19), was reported in Wuhan, China (1).On January 7, 2020, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV, was identified as the causative agent of the outbreak (2).On January 10, 2020, a SARS-CoV-2 genome sequence was shared with the global scientific community through an online resource (3).The virus was genetically most closely related to SARS-CoV and SARS-related bat and civet coronaviruses within the family Betacoronavirus, subgenus Sarbecovirus (4,5).To support the potential public health emergency response to COVID-19, the Centers for Disease Control and Prevention (CDC) developed and validated a real-time reverse transcription PCR (rRT-PCR) panel based on this SARS-CoV-2 genome sequence (3).The panel targeted the nucleocapsid protein (N) gene of SARS-CoV-2.The rRT-PCR panel was validated under the Clinical Laboratory Improvement Amendments (https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA) for CDC use for diagnosis of SARS-CoV-2 from respiratory clinical specimens.On January 20, 2020, the CDC rRT-PCR panel confirmed an early case of COVID-19 in the United States (6).The US Food and Drug Administration issued an Emergency Use Authorization to enable emergency use of the CDC rRT-PCR panel as an in vitro diagnostic test for SARS-CoV-2 (https:// www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-responseefforts-issues-emergency-use-authorization-first).From January 18 through February 27, as part of the COVID-19 response, CDC tested 2,923 specimens from 998 persons for SARS-CoV-2.As of April 22, ≈2,400,000 confirmed COVID-19 cases and ≈169,000 associated deaths had been identified globally, including ≈770,000 cases and ≈37,000 deaths in the United States (7).We describe the design and validation of the CDC rRT-PCR panel and present comprehensive data on its performance with US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid2608.201246

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 676

Metadata

Authors
Lu, X., Wang, L., Sakthivel, S. K., Whitaker, B., Murray, J., Kamili, S., Lynch, B., Malapati, L., Burke, S. A., Harcourt, J., Tamin, A., Thornburg, N. J., Villanueva, J. M., & Lindstrom, S.
Venue
Emerging Infectious Diseases
Published
2020-08
Volume
26
Issue
8
Pages
1654-1665
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W3024623392
Cited by
676
References
18
FWCI
13.97
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.